SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-022190
Filing Date
2024-05-31
Accepted
2024-05-31 16:05:31
Documents
13
Period of Report
2024-05-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 44467
  Complete submission text file 0001493152-24-022190.txt   218150

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE jan-20240528.xsd EX-101.SCH 3006
3 XBRL LABEL FILE jan-20240528_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE jan-20240528_pre.xml EX-101.PRE 22354
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3680
Mailing Address 325 E. WARM SPRINGS ROAD SUITE 102 LAS VEGAS NV 89119
Business Address 325 E. WARM SPRINGS ROAD SUITE 102 LAS VEGAS NV 89119 702-997-5968
JanOne Inc. (Filer) CIK: 0000862861 (see all company filings)

IRS No.: 411454591 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19621 | Film No.: 241009629
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)